Statistics for KalVista Pharmaceuticals (id:6660 KALV)
Valuation metrics
Market cap
499.54M
Enterprise value
234.96M
Trailing P/E (ttm)
-2.95
Forward P/E
-5.43
PEG ratio
-5.43
Price/Sales (ttm)
Price/Book (mrq)
2.53
Enterprise Value/Revenue
Enterprise Value/EBITDA
-1.52
Overview
Shares outstanding
49.22M
Float
24.88M
Shares short
6.87M
% Held by insiders
0.01%
% Held by institutions
1.10%
Average volume (10 days)
517.44K
Average volume (90 days)
Price summary
52-Week low
7.39
52-Week high
16.88
52-Week change
20.39%
Beta
0.91
50-Day moving average
11.04
200-Day moving average
12.15
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
November 22th, 2016
Ex-dividend date
Last split factor
2:1
Last split date
November 22th, 2016
Financials
Fiscal yearFiscal year ends
April 30th, 2024
Most recent quarter (mrq)
July 31th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-53.94%
Return on equity
-90.84%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-154,720,000.00
Net income to common (ttm)
-141,770,000.00
Diluted EPS (ttm)
-3.57
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
174.27M
Total cash per share (mrq)
4.03
Total debt (mrq)
6.25M
Total Debt/Equity (mrq)
3.62
Current ratio (mrq)
855.10%
Book value per share (mrq)
4.01
Cash flow
Cash flow statement
-102,721,000.00
Levered free cash flow (LFCF)
-57,843,376.00